Biocompatible and pH-Sensitive PLGA Encapsulated MnO Nanocrystals for Molecular and Cellular MRI
- 15 April 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 5 (5), 3438-3446
- https://doi.org/10.1021/nn1019779
Abstract
Inorganic manganese-based particles are becoming attractive for molecular and cellular imaging, due to their ability to provide bright contrast on MRI, as opposed to the dark contrast generated from iron-based particles. Using a single emulsion technique, we have successfully fabricated pH-sensitive poly(lactic-co-glycolic acid) (PLGA)-encapsulated manganese oxide (MnO) nanocrystals. Two classes of particles were fabricated at ∼140 nm and 1.7 μm and incorporated 15 to 20 nm MnO nanocrystals with high encapsulation efficiencies. Intact particles at physiological pH cause little contrast in MRI, but following endocytosis into low pH compartments within the cells, the particles erode and MnO dissolves to release Mn2+. This causes the cells to appear bright on MR images. The magnitude of the change in MRI properties is as high as 35-fold, making it the most dynamic “smart” MRI contrast agent yet reported. Possible applications of these MnO particles include slow release Mn2+, tumor targeting, and confirmation of cell uptake.Keywords
This publication has 40 references indexed in Scilit:
- Retrograde axonal tracing using manganese enhanced magnetic resonance imagingNeuroImage, 2010
- Experimental protocol for activation-induced manganese-enhanced MRI (AIM-MRI) based on quantitative determination of Mn content in rat brain by fast T 1 mappingMagnetic Resonance in Medicine, 2009
- In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell linesBioprocess and Biosystems Engineering, 2009
- Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloidsChemical Communications, 2009
- Convertible manganese contrast for molecular and cellular MRIMagnetic Resonance in Medicine, 2008
- MR tracking of transplanted cells with “positive contrast” using manganese oxide nanoparticlesMagnetic Resonance in Medicine, 2008
- The synthesis and in vitro testing of a zinc-activated MRI contrast agentProceedings of the National Academy of Sciences of the United States of America, 2007
- In vivo detection of single cells by MRIMagnetic Resonance in Medicine, 2006
- Cell labeling for magnetic resonance imaging with theT1 agent manganese chlorideNMR in Biomedicine, 2006
- Stability and transmetallation of the magnetic resonance contrast agent MnDPDP measured by EPRJBIC Journal of Biological Inorganic Chemistry, 2002